ADAR1-regulated miR-142-3p/RIG-I axis suppresses antitumor immunity in nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ADAR1-regulated miR-142-3p/RIG-I axis suppresses antitumor immunity in nasopharyngeal carcinoma

Published:2024-08 Issue: Volume: Page:
ISSN:2468-0540
Container-title:Non-coding RNA Research
language:en
Short-container-title:Non-coding RNA Research

Author:

Xu Haoyuan,Li Wanpeng,Xue Kai,Zhang Huankang,Li Han,Yu Haoran,Hu Li,Gu Yurong,Li Houyong,Sun Xicai^ORCID,Liu Quan,Wang Dehui^ORCID

Funder

National Natural Science Foundation of China

Shanghai Municipal Health Commission

National Key Research and Development Program of China

Shanghai Shen Kang Hospital Development Center

Science and Technology Commission of Shanghai Municipality

Publisher

Elsevier BV

Reference40 articles.

1. Global trends in incidence and mortality of nasopharyngeal carcinoma;Tang;Cancer Lett.,2016

2. Nasopharyngeal carcinoma incidence and mortality in China in 2010;Wei;Chin J Cancer,2014

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J Chin,2021

4. Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study;Ding;J Clin Oncol,2023

5. DIANA-microT 2023: including predicted targets of virally encoded miRNAs;Tastsoglou;Nucleic Acids Res,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP